Clin2
NCT07621107Possibly a fitNot yet recruiting

Chinese herbal medicine for heart blood flow after heart attack

STEMI (ST Elevation MI)STEMI - ST Elevation Myocardial InfarctionSTEMICMDCoronary Microvascular Dysfunction (CMD)

Part of Heart & circulation clinical trials.

This trial tests whether Guanxinning Tablet, a Chinese herbal medicine, can improve blood flow in the tiny vessels of the heart after an acute heart attack (STEMI) treated with emergency angioplasty. The study measures heart function changes over 6 months using imaging.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
70 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • Age 18–80 years old
  • Recent first-time STEMI (heart attack with ST-segment elevation) diagnosed within the last 12 hours
  • Successfully treated with primary percutaneous coronary intervention (emergency angioplasty) with good blood flow restored
  • Heart function (LVEF) of 40% or higher
  • Able to complete 6 months of treatment and cardiac MRI imaging
  • Not currently taking nicorandil, other Chinese patent medicines, or herbal decoctions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06935383Not yet recruiting· Phase 2
Treating microvessel injury after heart attack

This trial tests treatments for small blood vessel damage after a major heart attack (STEMI). If you have had a heart attack and are receiving a stent, this study may help improve recovery by targeting microvascular injury.

NCT07689591Recruiting
Non-invasive blood flow boost for heart attack patients

This trial tests a non-invasive method to improve blood flow in the arm during a heart attack. It may help reduce heart muscle damage before the standard artery-opening procedure.

Elâzığ, Elaziğ
NCT07616544Not yet recruiting· Phase 3
Chinese Herbal Treatment After Heart Artery Opening

This study tests whether a Chinese herbal medicine called Qidan Xiaoke Granules can help patients recover better after a procedure to open blocked heart arteries (called PCI). The goal is to see if this herbal treatment reduces heart problems after the procedure.

NCT07153744Not yet recruiting· Phase 4
Shexiang Baoxin Pill for Heart Attack Treatment

This trial tests if a traditional Chinese medicine pill (Shexiang Baoxin) can help people having a heart attack. It is given along with standard care, including a procedure to open blocked heart arteries (PCI).

Shanghai
NCT06845254Not yet recruiting· Phase 3
Study of Xuesaitong Soft Capsules after heart stent placement

This trial tests whether Xuesaitong Soft Capsules can help people who recently had a heart attack or unstable angina and received a stent. It aims to see if adding this medicine improves recovery and reduces future heart problems.

Beijing
NCT07088523Not yet recruiting· Phase 4
Chinese medicine for heart attack with diabetes

This study tests whether a traditional Chinese medicine treatment can help people who've just had a heart attack and also have type 2 diabetes. It compares the Chinese medicine approach to standard care.

Guangzhou, Guangdong

Hear when a new STEMI (ST Elevation MI) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.